Patents Assigned to OptiScan Biomedical Corp.
  • Patent number: 9289169
    Abstract: Some embodiments provide a system for synchronizing and configuring monitoring devices. In some embodiments, a patient monitoring device settings module is configured to automatically provide configuration settings to a plurality of patient monitoring devices. A monitoring device data module is configured to receive measurement data from at least one of the patient monitoring devices. An electronic medical records system interface is configured to provide patient data at least partially derived from the received measurement data to an electronic medical records system. A patient records interface is configured to provide patient data to at least one of the patient monitoring devices.
    Type: Grant
    Filed: November 22, 2013
    Date of Patent: March 22, 2016
    Assignee: OptiScan Biomedical Corp.
    Inventors: Peter Rule, Gil Rivas
  • Patent number: 9091676
    Abstract: Systems and methods for analyzing multiple components of a fluid sample are provided. In certain embodiments, a system can include an analyte detection system configured to measure first analyte data in a first component of a fluid sample received from a patient and measure second analyte data in a second component of a fluid sample. In some embodiments, one or more portions of an optical system is movable with respect to other portions of the system in order to optically and/or electrochemically analyze multiple components of a fluid sample. In other embodiments, optical and/or electrochemical analysis can be performed simultaneously on multiple components of a fluid sample. In some embodiments, a first analyte can be measured in a sample (e.g., whole blood) before the sample is separated into its components (e.g., plasma, red blood cells, etc.), and a second analyte can be measured in a component of the sample after separation.
    Type: Grant
    Filed: June 8, 2011
    Date of Patent: July 28, 2015
    Assignee: OptiScan Biomedical Corp.
    Inventors: Peter Rule, James R. Braig, Richard Keenan, II, David Callicoat
  • Patent number: 7722537
    Abstract: An apparatus for analyzing the composition of bodily fluid. The apparatus comprises a fluid handling network including a patient end configured to maintain fluid communication with a bodily fluid in a patient and at least one pump intermittently operable to draw a sample of bodily fluid from the patient. The apparatus further comprises a fluid analyzer positioned to analyze at least a portion of the sample and measure the presence of two or more analytes. Also disclosed is a method for analyzing the composition of a bodily fluid in a patient. The method comprises drawing a sample of the bodily fluid of the patient through a fluid handling network configured to maintain fluid communication with a bodily fluid in a patient. The method further comprises analyzing the at least a portion of the sample in a fluid analyzer to estimate the concentration of two or more analytes in the sample.
    Type: Grant
    Filed: December 21, 2005
    Date of Patent: May 25, 2010
    Assignee: OptiScan Biomedical Corp.
    Inventors: Bernhard B. Sterling, James R. Braig, Peter Rule, W. Dale Hall, Mark Wechsler, Jennifer H. Gable
  • Patent number: 7364562
    Abstract: A method for maintaining clear passageways in an extracorporeal blood flow system. The method comprises intermittently providing one or more anti-clotting agents to a passageway of the extracorporeal blood flow system. Also disclosed is an extracorporeal blood flow system. The system comprises a passageway, and a device operatively connected to provide one or more anti-clotting agents to a least a portion of said passageway.
    Type: Grant
    Filed: December 21, 2005
    Date of Patent: April 29, 2008
    Assignee: OptiScan Biomedical Corp.
    Inventors: James R. Braig, Richard Keenan
  • Patent number: 7061593
    Abstract: A reagentless whole-blood analyte detection system that is capable of being deployed near a patient has a source capable of emitting a beam of radiation that includes a spectral band. The whole-blood system also has a detector in an optical path of the beam. The whole-blood system also has a housing that is configured to house the source and the detector. The whole-blood system also has a sample element that is situated in the optical path of the beam. The sample element has a sample cell and a sample cell wall that does not eliminate transmittance of the beam of radiation in the spectral band.
    Type: Grant
    Filed: August 14, 2002
    Date of Patent: June 13, 2006
    Assignee: Optiscan Biomedical Corp.
    Inventors: James R. Braig, Peter Rule, Philip C. Hartstein
  • Patent number: 7050157
    Abstract: A reagentless whole-blood analyte detection system that is capable of being deployed near a patient has a source capable of emitting a beam of radiation that includes a spectral band. The whole-blood system also has a detector in an optical path of the beam. The whole-blood system also has a housing that is configured to house the source and the detector. The whole-blood system also has a sample element that is situated in the optical path of the beam. The sample element has a sample cell and a sample cell wall that does not eliminate transmittance of the beam of radiation in the spectral band.
    Type: Grant
    Filed: July 19, 2002
    Date of Patent: May 23, 2006
    Assignee: OptiScan Biomedical Corp.
    Inventors: James R. Braig, Peter Rule, Robert D. Gaffney, Philip C. Hartstein, Julian M. Cortella, Kenneth I. Li, Bernhard B. Sterling, Peng Zheng, W. Dale Hall, Kenneth G. Witte, Mark D. Agostino, Daniel S. Goldberger
  • Patent number: 7009180
    Abstract: A method uses spectroscopy to determine an analyte concentration in a sample. The method includes producing an absorbance spectrum of the sample. The method further includes shifting the absorbance spectrum to zero in a wavelength region. The method further includes subtracting a water or other substance contribution from the absorbance spectrum.
    Type: Grant
    Filed: December 12, 2002
    Date of Patent: March 7, 2006
    Assignee: Optiscan Biomedical Corp.
    Inventors: Bernhard B. Sterling, James R. Braig, Daniel S. Goldberger, Philip C. Hartstein, Robert D. Gaffney
  • Patent number: 6959211
    Abstract: A device and method are provided for use with a noninvasive optical measurement system, such as a thermal gradient spectrometer, for improved determination of analyte concentrations within living tissue. In one embodiment, a wearable window is secured to a patient's forearm thereby isolating a measurement site on the patient's skin for determination of blood glucose levels. The wearable window effectively replaces a window of the spectrometer, and thus forms an interface between the patient's skin and a thermal mass window of the spectrometer. When the spectrometer must be temporarily removed from the patient's skin, such as to allow the patient mobility, the wearable window is left secured to the forearm so as to maintain a consistent measurement site on the skin. When the spectrometer is later reattached to the patient, the wearable window will again form an interface between the spectrometer and the same location of skin as before.
    Type: Grant
    Filed: August 6, 2002
    Date of Patent: October 25, 2005
    Assignee: OptiScan Biomedical Corp.
    Inventors: Peter Rule, James R. Braig, Daniel S. Goldberger, Julian M. Cortella, Heidi M. Smith, Roger O. Herrera, Kenneth G. Witte, Philip C. Hartstein, Mark D. Agostino
  • Patent number: 6931328
    Abstract: An analyte concentration monitoring system having network-based communication features which provide a link between an analyte detection system and a centralized computer. The analyte detection system has a processor that calculates analyte concentration in accordance with software executable by the processor. Under certain conditions, the software needs to be updated. Accordingly, when the analyte detection system is connected to the centralized computer, the centralized computer determines whether a software update is needed. If a software update is needed, then the centralized computer conveniently provides the software update to the analyte detection system without intervention from a user.
    Type: Grant
    Filed: November 8, 2002
    Date of Patent: August 16, 2005
    Assignee: OptiScan Biomedical Corp.
    Inventors: James R. Braig, Gary E. Hewett, Michael A. Munrow, Julian M. Cortella, Kamrava Azizi, Daniel S. Goldberger
  • Patent number: 6731961
    Abstract: A device and method for determining analyte concentrations within a material sample are provided. A modulating temperature gradient is induced in the sample and resultant, emitted infrared radiation is measured at selected analyte absorbance peaks and reference wavelengths. The modulating temperature gradient is controlled by a surface temperature modulation. One embodiment provides a transfer function relating the surface temperature modulation to a modulation of the measured infrared radiation. Phase and magnitude differences in the transfer function are detected in the presence of the sought-after analyte. These phase and magnitude differences, having a relationship to analyte concentration, are measured, correlated and processed to determine analyte concentration in the material sample. Another embodiment provides a method for transforming thermal phase spectra to absorption spectra for consistent determination of analyte concentration within the sample.
    Type: Grant
    Filed: November 8, 2002
    Date of Patent: May 4, 2004
    Assignee: OptiScan Biomedical Corp.
    Inventors: James R. Braig, W. Dale Hall, Casper W. Barnes, Peng Zheng, Jennifer H. Gable
  • Patent number: 6678542
    Abstract: A method calibrates a monitor that comprises a non-invasive blood constituent monitor and a traditional measurement system. The non-invasive blood constituent monitor includes a thermal gradient inducing element an analyzer window. A traditional monitor output representing a property of a blood constituent is generated by the traditional measurement system. A non-invasive monitor output representing the property of the whole blood constituent is generated by the non-invasive constituent monitor. The traditional monitor output and the non-invasive monitor output are compared to estimate an amount of error. The non-invasive monitor output is corrected by the amount of error.
    Type: Grant
    Filed: November 2, 2001
    Date of Patent: January 13, 2004
    Assignee: OptiScan Biomedical Corp.
    Inventors: James R. Braig, Peter Rule, Bernhard B. Sterling, Heidi M. Smith, Julian M. Cortella, Jennifer H. Gable